NeOnc to hold FDA meeting on NEO212 for glioma programSep 28Clinical readoutNEO212Neonc Technologies, Inc.
NeOnc CEO buys more stock after positive NEO100 Phase 2a dataSep 17Clinical readoutNeonc Technologies, Inc.perillyl alcohol
NeOnc confirms August 12 topline readout for Phase 2a NEO100 glioma studyAug 10Clinical readoutNEO212Neonc Technologies, Inc.
Sign inSign in